Aperio Technologies

About:

Aperio Technologies provides digital pathology solutions for hospitals, reference labs, and pharmaceutical and research institutions.

Website: http://www.aperio.com

Twitter/X: AperioDP

Top Investors: BlackRock, Goldman Sachs, Advanced Technology Ventures, Mobius Venture Capital, HLM Venture Partners

Description:

Aperio is the leading provider of digital pathology solutions in hospitals, reference labs, and pharmaceutical and research institutions across the world. Today, our affordable and complete product portfolio improves patient care by enhancing quality assurance, delivering more efficient workflows, facilitating access to new and more targeted therapies, and improving pathologists' skills via lifelong education. Our comprehensive product line features our ScanScope® scanners, Spectrum™ image management (PACS) software, SecondSlide® slide sharing service for pathology, and image analysis tools and services. Aperio's products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications.

Total Funding Amount:

$61.6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Vista, California, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)aperio.com

Founders:

Dirk G. Soenksen

Number of Employees:

51-100

Last Funding Date:

2012-08-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai